Your session is about to expire
← Back to Search
HPV Education Interventions for Health Personnel Attitudes
N/A
Recruiting
Led By Eva M Moya, PhD, LMSW
Research Sponsored by University of Texas, El Paso
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately post-intervention (0 months), 3 months post-intervention, and 6 months post-intervention
Awards & highlights
Study Summary
This trial will compare two interventions to see which is more effective at reducing HPV vaccine hesitancy and increasing uptake and completion among people living in the El Paso U.S.-Mexico Border Region.
Who is the study for?
This trial is for current or future healthcare providers who can prescribe/administer the HPV vaccine and are based in the El Paso U.S.-Mexico Border Region. They must be able to participate fully and follow up in English. Those already part of earlier phases of this research or not affiliated with the specified region cannot join.Check my eligibility
What is being tested?
The study tests two types of interventions on healthcare providers: a tailored education program about HPV and professional skills training versus general HPV education. The goal is to see if these methods improve their knowledge, attitudes, and communication strategies regarding HPV vaccination.See study design
What are the potential side effects?
Since this trial focuses on educational interventions rather than medical treatments, there are no direct physical side effects expected from participating. However, participants may experience changes in attitude or increased workload due to intervention activities.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately post-intervention (0 months), 3 months post-intervention, and 6 months post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately post-intervention (0 months), 3 months post-intervention, and 6 months post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Between-group changes in proportions from post-intervention scores of the Healthcare Provider (HCP) Practices scale on the Healthcare Personnel Survey
Secondary outcome measures
Between-group changes in proportions from post-intervention scores of the Human Papillomavirus (HPV) Vaccine Attitudes scale on the Healthcare Personnel Survey
Between-group changes in proportions from post-intervention scores on the Human Papillomavirus (HPV) Knowledge scale on the Healthcare Personnel Survey
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
A tailored HPV education and professional skills intervention.
Group II: ControlActive Control1 Intervention
General/publicly available educational materials on HPV and communication skills.
Find a Location
Who is running the clinical trial?
Burrell College of Osteopathic MedicineOTHER
4 Previous Clinical Trials
146 Total Patients Enrolled
University of Texas, El PasoLead Sponsor
13 Previous Clinical Trials
2,543 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,216,061 Total Patients Enrolled
2 Trials studying Health Literacy
1,057 Patients Enrolled for Health Literacy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot or do not want to commit to the full study duration and activities.I am authorized to handle the HPV vaccine.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research project available to individuals who are younger than 45 years of age?
"This research endeavour is actively seeking participants with ages between 18 and 65."
Answered by AI
To which demographic is enrollment in this trial open?
"Patients who are aged between 18 to 65 and healthcare providers in El Paso, Texas-Southern New mexico area can participate in this study. The criteria for potential participants is that they must be either current medical practitioners or those training to become one, with the added requirement of living/practicing within the designated border region."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger